Global Alzheimer's Disease Diagnosis Supply, Demand and Key Producers, 2024-2030

Description

The Alzheimer's Disease Diagnosis market encompasses the tools, technologies, and services used to detect and diagnose Alzheimer's disease, a progressive neurodegenerative disorder. This market includes diagnostic methods such as imaging techniques (like PET, MRI, and CT scans), biomarker testing (blood, cerebrospinal fluid, and genetic testing), cognitive assessment tools, and novel diagnostic solutions like digital health tools and AI-based diagnostics. The growing prevalence of Alzheimer’s, increasing awareness of early detection, and advancements in diagnostic technologies are driving market growth. Pharmaceutical companies, research institutions, and healthcare providers play key roles in expanding diagnostic options. However, challenges such as the high cost of advanced diagnostic tools and limited access to specialized testing in certain regions can restrain the market’s growth. The Alzheimer's Disease Diagnosis market is critical for facilitating early and accurate diagnosis, which can improve patient management and outcomes.

The global Alzheimer's Disease Diagnosis market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Alzheimer's Disease Diagnosis demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Alzheimer's Disease Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alzheimer's Disease Diagnosis that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Alzheimer's Disease Diagnosis total market, 2019-2030, (USD Million)
Global Alzheimer's Disease Diagnosis total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Alzheimer's Disease Diagnosis total market, key domestic companies, and share, (USD Million)
Global Alzheimer's Disease Diagnosis revenue by player, revenue and market share 2019-2024, (USD Million)
Global Alzheimer's Disease Diagnosis total market by Type, CAGR, 2019-2030, (USD Million)
Global Alzheimer's Disease Diagnosis total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Alzheimer's Disease Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, EUROIMMUN Medical Diagnostics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Alzheimer's Disease Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Alzheimer's Disease Diagnosis Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Alzheimer's Disease Diagnosis Market, Segmentation by Type
    Neuroimaging Examination
    Cerebrospinal Fluid Examination
    Peripheral Blood Antibody Examination
    Others

Global Alzheimer's Disease Diagnosis Market, Segmentation by Application:
    Clinical Diagnosis
    Research

Companies Profiled:
    Roche
    Quanterix
    Quest Diagnostics
    C₂N Diagnostics
    Fujirebio
    Diadem
    Labcorp
    Neurocode
    Cognitact
    EUROIMMUN Medical Diagnostics
    Vazyme International
    KingMed Diagnostics
    Hoyotek
    Carrier Biomed

Key Questions Answered
1. How big is the global Alzheimer's Disease Diagnosis market?
2. What is the demand of the global Alzheimer's Disease Diagnosis market?
3. What is the year over year growth of the global Alzheimer's Disease Diagnosis market?
4. What is the total value of the global Alzheimer's Disease Diagnosis market?
5. Who are the Major Players in the global Alzheimer's Disease Diagnosis market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Alzheimer's Disease Diagnosis Introduction
    1.2 World Alzheimer's Disease Diagnosis Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Alzheimer's Disease Diagnosis Total Market by Region (by Headquarter Location)
        1.3.1 World Alzheimer's Disease Diagnosis Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
        1.3.3 China Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
        1.3.4 Europe Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
        1.3.5 Japan Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
        1.3.6 South Korea Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
        1.3.7 ASEAN Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
        1.3.8 India Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Alzheimer's Disease Diagnosis Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.2 World Alzheimer's Disease Diagnosis Consumption Value by Region
        2.2.1 World Alzheimer's Disease Diagnosis Consumption Value by Region (2019-2024)
        2.2.2 World Alzheimer's Disease Diagnosis Consumption Value Forecast by Region (2025-2030)
    2.3 United States Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.4 China Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.5 Europe Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.6 Japan Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.7 South Korea Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.8 ASEAN Alzheimer's Disease Diagnosis Consumption Value (2019-2030)
    2.9 India Alzheimer's Disease Diagnosis Consumption Value (2019-2030)

3 World Alzheimer's Disease Diagnosis Companies Competitive Analysis
    3.1 World Alzheimer's Disease Diagnosis Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Alzheimer's Disease Diagnosis Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Alzheimer's Disease Diagnosis in 2023
        3.2.3 Global Concentration Ratios (CR8) for Alzheimer's Disease Diagnosis in 2023
    3.3 Alzheimer's Disease Diagnosis Company Evaluation Quadrant
    3.4 Alzheimer's Disease Diagnosis Market: Overall Company Footprint Analysis
        3.4.1 Alzheimer's Disease Diagnosis Market: Region Footprint
        3.4.2 Alzheimer's Disease Diagnosis Market: Company Product Type Footprint
        3.4.3 Alzheimer's Disease Diagnosis Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Alzheimer's Disease Diagnosis Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Alzheimer's Disease Diagnosis Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Alzheimer's Disease Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Alzheimer's Disease Diagnosis Consumption Value Comparison
        4.2.1 United States VS China: Alzheimer's Disease Diagnosis Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Alzheimer's Disease Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Alzheimer's Disease Diagnosis Companies and Market Share, 2019-2024
        4.3.1 United States Based Alzheimer's Disease Diagnosis Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Alzheimer's Disease Diagnosis Revenue, (2019-2024)
    4.4 China Based Companies Alzheimer's Disease Diagnosis Revenue and Market Share, 2019-2024
        4.4.1 China Based Alzheimer's Disease Diagnosis Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Alzheimer's Disease Diagnosis Revenue, (2019-2024)
    4.5 Rest of World Based Alzheimer's Disease Diagnosis Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Alzheimer's Disease Diagnosis Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Alzheimer's Disease Diagnosis Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Alzheimer's Disease Diagnosis Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Neuroimaging Examination
        5.2.2 Cerebrospinal Fluid Examination
        5.2.3 Peripheral Blood Antibody Examination
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Alzheimer's Disease Diagnosis Market Size by Type (2019-2024)
        5.3.2 World Alzheimer's Disease Diagnosis Market Size by Type (2025-2030)
        5.3.3 World Alzheimer's Disease Diagnosis Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Alzheimer's Disease Diagnosis Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Clinical Diagnosis
        6.2.2 Research
    6.3 Market Segment by Application
        6.3.1 World Alzheimer's Disease Diagnosis Market Size by Application (2019-2024)
        6.3.2 World Alzheimer's Disease Diagnosis Market Size by Application (2025-2030)
        6.3.3 World Alzheimer's Disease Diagnosis Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Alzheimer's Disease Diagnosis Product and Services
        7.1.4 Roche Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Quanterix
        7.2.1 Quanterix Details
        7.2.2 Quanterix Major Business
        7.2.3 Quanterix Alzheimer's Disease Diagnosis Product and Services
        7.2.4 Quanterix Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Quanterix Recent Developments/Updates
        7.2.6 Quanterix Competitive Strengths & Weaknesses
    7.3 Quest Diagnostics
        7.3.1 Quest Diagnostics Details
        7.3.2 Quest Diagnostics Major Business
        7.3.3 Quest Diagnostics Alzheimer's Disease Diagnosis Product and Services
        7.3.4 Quest Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Quest Diagnostics Recent Developments/Updates
        7.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
    7.4 C₂N Diagnostics
        7.4.1 C₂N Diagnostics Details
        7.4.2 C₂N Diagnostics Major Business
        7.4.3 C₂N Diagnostics Alzheimer's Disease Diagnosis Product and Services
        7.4.4 C₂N Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 C₂N Diagnostics Recent Developments/Updates
        7.4.6 C₂N Diagnostics Competitive Strengths & Weaknesses
    7.5 Fujirebio
        7.5.1 Fujirebio Details
        7.5.2 Fujirebio Major Business
        7.5.3 Fujirebio Alzheimer's Disease Diagnosis Product and Services
        7.5.4 Fujirebio Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Fujirebio Recent Developments/Updates
        7.5.6 Fujirebio Competitive Strengths & Weaknesses
    7.6 Diadem
        7.6.1 Diadem Details
        7.6.2 Diadem Major Business
        7.6.3 Diadem Alzheimer's Disease Diagnosis Product and Services
        7.6.4 Diadem Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Diadem Recent Developments/Updates
        7.6.6 Diadem Competitive Strengths & Weaknesses
    7.7 Labcorp
        7.7.1 Labcorp Details
        7.7.2 Labcorp Major Business
        7.7.3 Labcorp Alzheimer's Disease Diagnosis Product and Services
        7.7.4 Labcorp Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Labcorp Recent Developments/Updates
        7.7.6 Labcorp Competitive Strengths & Weaknesses
    7.8 Neurocode
        7.8.1 Neurocode Details
        7.8.2 Neurocode Major Business
        7.8.3 Neurocode Alzheimer's Disease Diagnosis Product and Services
        7.8.4 Neurocode Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Neurocode Recent Developments/Updates
        7.8.6 Neurocode Competitive Strengths & Weaknesses
    7.9 Cognitact
        7.9.1 Cognitact Details
        7.9.2 Cognitact Major Business
        7.9.3 Cognitact Alzheimer's Disease Diagnosis Product and Services
        7.9.4 Cognitact Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Cognitact Recent Developments/Updates
        7.9.6 Cognitact Competitive Strengths & Weaknesses
    7.10 EUROIMMUN Medical Diagnostics
        7.10.1 EUROIMMUN Medical Diagnostics Details
        7.10.2 EUROIMMUN Medical Diagnostics Major Business
        7.10.3 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product and Services
        7.10.4 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 EUROIMMUN Medical Diagnostics Recent Developments/Updates
        7.10.6 EUROIMMUN Medical Diagnostics Competitive Strengths & Weaknesses
    7.11 Vazyme International
        7.11.1 Vazyme International Details
        7.11.2 Vazyme International Major Business
        7.11.3 Vazyme International Alzheimer's Disease Diagnosis Product and Services
        7.11.4 Vazyme International Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Vazyme International Recent Developments/Updates
        7.11.6 Vazyme International Competitive Strengths & Weaknesses
    7.12 KingMed Diagnostics
        7.12.1 KingMed Diagnostics Details
        7.12.2 KingMed Diagnostics Major Business
        7.12.3 KingMed Diagnostics Alzheimer's Disease Diagnosis Product and Services
        7.12.4 KingMed Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 KingMed Diagnostics Recent Developments/Updates
        7.12.6 KingMed Diagnostics Competitive Strengths & Weaknesses
    7.13 Hoyotek
        7.13.1 Hoyotek Details
        7.13.2 Hoyotek Major Business
        7.13.3 Hoyotek Alzheimer's Disease Diagnosis Product and Services
        7.13.4 Hoyotek Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Hoyotek Recent Developments/Updates
        7.13.6 Hoyotek Competitive Strengths & Weaknesses
    7.14 Carrier Biomed
        7.14.1 Carrier Biomed Details
        7.14.2 Carrier Biomed Major Business
        7.14.3 Carrier Biomed Alzheimer's Disease Diagnosis Product and Services
        7.14.4 Carrier Biomed Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Carrier Biomed Recent Developments/Updates
        7.14.6 Carrier Biomed Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Alzheimer's Disease Diagnosis Industry Chain
    8.2 Alzheimer's Disease Diagnosis Upstream Analysis
    8.3 Alzheimer's Disease Diagnosis Midstream Analysis
    8.4 Alzheimer's Disease Diagnosis Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Alzheimer's Disease Diagnosis Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Alzheimer's Disease Diagnosis Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Alzheimer's Disease Diagnosis Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Alzheimer's Disease Diagnosis Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Alzheimer's Disease Diagnosis Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Alzheimer's Disease Diagnosis Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Alzheimer's Disease Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Alzheimer's Disease Diagnosis Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Alzheimer's Disease Diagnosis Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Alzheimer's Disease Diagnosis Players in 2023
 Table 12. World Alzheimer's Disease Diagnosis Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Alzheimer's Disease Diagnosis Company Evaluation Quadrant
 Table 14. Head Office of Key Alzheimer's Disease Diagnosis Players
 Table 15. Alzheimer's Disease Diagnosis Market: Company Product Type Footprint
 Table 16. Alzheimer's Disease Diagnosis Market: Company Product Application Footprint
 Table 17. Alzheimer's Disease Diagnosis Mergers & Acquisitions Activity
 Table 18. United States VS China Alzheimer's Disease Diagnosis Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Alzheimer's Disease Diagnosis Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Alzheimer's Disease Diagnosis Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Alzheimer's Disease Diagnosis Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Alzheimer's Disease Diagnosis Revenue Market Share (2019-2024)
 Table 23. China Based Alzheimer's Disease Diagnosis Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Alzheimer's Disease Diagnosis Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Alzheimer's Disease Diagnosis Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Alzheimer's Disease Diagnosis Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Alzheimer's Disease Diagnosis Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Alzheimer's Disease Diagnosis Revenue Market Share (2019-2024)
 Table 29. World Alzheimer's Disease Diagnosis Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Alzheimer's Disease Diagnosis Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Alzheimer's Disease Diagnosis Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Alzheimer's Disease Diagnosis Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Alzheimer's Disease Diagnosis Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Alzheimer's Disease Diagnosis Market Size by Application (2025-2030) & (USD Million)
 Table 35. Roche Basic Information, Manufacturing Base and Competitors
 Table 36. Roche Major Business
 Table 37. Roche Alzheimer's Disease Diagnosis Product and Services
 Table 38. Roche Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Roche Recent Developments/Updates
 Table 40. Roche Competitive Strengths & Weaknesses
 Table 41. Quanterix Basic Information, Manufacturing Base and Competitors
 Table 42. Quanterix Major Business
 Table 43. Quanterix Alzheimer's Disease Diagnosis Product and Services
 Table 44. Quanterix Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Quanterix Recent Developments/Updates
 Table 46. Quanterix Competitive Strengths & Weaknesses
 Table 47. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
 Table 48. Quest Diagnostics Major Business
 Table 49. Quest Diagnostics Alzheimer's Disease Diagnosis Product and Services
 Table 50. Quest Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Quest Diagnostics Recent Developments/Updates
 Table 52. Quest Diagnostics Competitive Strengths & Weaknesses
 Table 53. C₂N Diagnostics Basic Information, Manufacturing Base and Competitors
 Table 54. C₂N Diagnostics Major Business
 Table 55. C₂N Diagnostics Alzheimer's Disease Diagnosis Product and Services
 Table 56. C₂N Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. C₂N Diagnostics Recent Developments/Updates
 Table 58. C₂N Diagnostics Competitive Strengths & Weaknesses
 Table 59. Fujirebio Basic Information, Manufacturing Base and Competitors
 Table 60. Fujirebio Major Business
 Table 61. Fujirebio Alzheimer's Disease Diagnosis Product and Services
 Table 62. Fujirebio Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Fujirebio Recent Developments/Updates
 Table 64. Fujirebio Competitive Strengths & Weaknesses
 Table 65. Diadem Basic Information, Manufacturing Base and Competitors
 Table 66. Diadem Major Business
 Table 67. Diadem Alzheimer's Disease Diagnosis Product and Services
 Table 68. Diadem Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Diadem Recent Developments/Updates
 Table 70. Diadem Competitive Strengths & Weaknesses
 Table 71. Labcorp Basic Information, Manufacturing Base and Competitors
 Table 72. Labcorp Major Business
 Table 73. Labcorp Alzheimer's Disease Diagnosis Product and Services
 Table 74. Labcorp Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Labcorp Recent Developments/Updates
 Table 76. Labcorp Competitive Strengths & Weaknesses
 Table 77. Neurocode Basic Information, Manufacturing Base and Competitors
 Table 78. Neurocode Major Business
 Table 79. Neurocode Alzheimer's Disease Diagnosis Product and Services
 Table 80. Neurocode Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Neurocode Recent Developments/Updates
 Table 82. Neurocode Competitive Strengths & Weaknesses
 Table 83. Cognitact Basic Information, Manufacturing Base and Competitors
 Table 84. Cognitact Major Business
 Table 85. Cognitact Alzheimer's Disease Diagnosis Product and Services
 Table 86. Cognitact Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Cognitact Recent Developments/Updates
 Table 88. Cognitact Competitive Strengths & Weaknesses
 Table 89. EUROIMMUN Medical Diagnostics Basic Information, Manufacturing Base and Competitors
 Table 90. EUROIMMUN Medical Diagnostics Major Business
 Table 91. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product and Services
 Table 92. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. EUROIMMUN Medical Diagnostics Recent Developments/Updates
 Table 94. EUROIMMUN Medical Diagnostics Competitive Strengths & Weaknesses
 Table 95. Vazyme International Basic Information, Manufacturing Base and Competitors
 Table 96. Vazyme International Major Business
 Table 97. Vazyme International Alzheimer's Disease Diagnosis Product and Services
 Table 98. Vazyme International Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Vazyme International Recent Developments/Updates
 Table 100. Vazyme International Competitive Strengths & Weaknesses
 Table 101. KingMed Diagnostics Basic Information, Manufacturing Base and Competitors
 Table 102. KingMed Diagnostics Major Business
 Table 103. KingMed Diagnostics Alzheimer's Disease Diagnosis Product and Services
 Table 104. KingMed Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. KingMed Diagnostics Recent Developments/Updates
 Table 106. KingMed Diagnostics Competitive Strengths & Weaknesses
 Table 107. Hoyotek Basic Information, Manufacturing Base and Competitors
 Table 108. Hoyotek Major Business
 Table 109. Hoyotek Alzheimer's Disease Diagnosis Product and Services
 Table 110. Hoyotek Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Hoyotek Recent Developments/Updates
 Table 112. Hoyotek Competitive Strengths & Weaknesses
 Table 113. Carrier Biomed Basic Information, Manufacturing Base and Competitors
 Table 114. Carrier Biomed Major Business
 Table 115. Carrier Biomed Alzheimer's Disease Diagnosis Product and Services
 Table 116. Carrier Biomed Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Carrier Biomed Recent Developments/Updates
 Table 118. Carrier Biomed Competitive Strengths & Weaknesses
 Table 119. Global Key Players of Alzheimer's Disease Diagnosis Upstream (Raw Materials)
 Table 120. Global Alzheimer's Disease Diagnosis Typical Customers


List of Figures
 Figure 1. Alzheimer's Disease Diagnosis Picture
 Figure 2. World Alzheimer's Disease Diagnosis Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Alzheimer's Disease Diagnosis Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Alzheimer's Disease Diagnosis Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Alzheimer's Disease Diagnosis Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Alzheimer's Disease Diagnosis Revenue (2019-2030) & (USD Million)
 Figure 13. Alzheimer's Disease Diagnosis Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Alzheimer's Disease Diagnosis Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Alzheimer's Disease Diagnosis by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Alzheimer's Disease Diagnosis Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Alzheimer's Disease Diagnosis Markets in 2023
 Figure 27. United States VS China: Alzheimer's Disease Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Alzheimer's Disease Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Alzheimer's Disease Diagnosis Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Alzheimer's Disease Diagnosis Market Size Market Share by Type in 2023
 Figure 31. Neuroimaging Examination
 Figure 32. Cerebrospinal Fluid Examination
 Figure 33. Peripheral Blood Antibody Examination
 Figure 34. Others
 Figure 35. World Alzheimer's Disease Diagnosis Market Size Market Share by Type (2019-2030)
 Figure 36. World Alzheimer's Disease Diagnosis Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World Alzheimer's Disease Diagnosis Market Size Market Share by Application in 2023
 Figure 38. Clinical Diagnosis
 Figure 39. Research
 Figure 40. World Alzheimer's Disease Diagnosis Market Size Market Share by Application (2019-2030)
 Figure 41. Alzheimer's Disease Diagnosis Industrial Chain
 Figure 42. Methodology
 Figure 43. Research Process and Data Source

Companies Mentioned

Roche
Quanterix
Quest Diagnostics
C₂N Diagnostics
Fujirebio
Diadem
Labcorp
Neurocode
Cognitact
EUROIMMUN Medical Diagnostics
Vazyme International
KingMed Diagnostics
Hoyotek
Carrier Biomed